Search Results 1511-1520 of 14753 for anti-TNF drugs

1. Plateletworks and Teg 6s Platelet Mapping Platelet Function Assays - Mayo Clinic

   ... medications or prescription anti-platelet agents for 10 days prior to study enrollment. For the 20 volunteers in the anti-platelet agent group, 20 patients ...

2. Duloxetine (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

3. A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis - Mayo Clinic

   There is preclinical evidence for efficacy of nintedanib in SSc and associated ILD (SSc-ILD) and the anti-fibrotic efficacy of nintedanib was proven in ...

4. Temozolomide and Irinotecan Hydrochloride with or without Bevacizumab in Treating Young Patients with Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors - Mayo Clinic

   Study Specific: Patients must not be currently taking nonsteroidal anti-inflammatory drugs (NSAIDs), clopidrogel, dipyridamole or aspirin therapy > 81 mg/day.

5. Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) (ESSENCE) - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... - Positive HBsAg, positive anti-HIV, positive HCV RNA at screening ( ...

6. New breast cancer drug is 'very exciting'

   "While the primary goal of the study was to safely deliver therapeutic levels of endoxifen, one of the most surprising observations was the prolonged anti ...

7. Zilucoplan (Subcutaneous Route) Description and Brand Names - Mayo Clinic

   Zilucoplan injection is used to treat a nerve and muscle problem called myasthenia gravis in patients who are anti-acetylcholine receptor (AChR) antibody ...

8. Coagulation Factor Viia (Intravenous Route) Before Using - Mayo Clinic

   ... medicines. Anti-Inhibitor Coagulant Complex; Factor XIII; Prothrombin Complex. Other Interactions. Certain medicines should not be used at or around the time of ...

9. HER2-Positive Breast Cancer Clinical Trials - Mayo Clinic Research

   The primary objective of this study is to demonstrate that the combination of palbociclib with anti-HER2 therapy plus endocrine therapy is superior to anti-HER2 ...

10. Head and Neck Cancer Center - Overview - Mayo Clinic

    However, depending on your needs, you may also have access to other drug therapies, such as immunotherapy and targeted drug therapy. Rehabilitation and overall ...